BRPI0615630A2 - pharmaceutical composition and use of sertindole - Google Patents

pharmaceutical composition and use of sertindole

Info

Publication number: BRPI0615630A2
Authority: BR; Brazil
Prior art keywords: sertindole; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2005-09-08

Application number

BRPI0615630A

Other languages

Portuguese (pt)

Inventor

Anne Ravnholdt Christensen

Fleming Enok Olsen

Ken Liljegren

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-08

Filing date

2006-09-06

Publication date

2016-11-16

2006-09-06 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2016-11-16 Publication of BRPI0615630A2 publication Critical patent/BRPI0615630A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Inorganic Chemistry (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0615630A 2005-09-08 2006-09-06 pharmaceutical composition and use of sertindole BRPI0615630A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200501255		2005-09-08
PCT/DK2006/050038 WO2007065448A1 (en)	2005-09-08	2006-09-06	Stable solid formulation of sertindole

Publications (1)

Publication Number	Publication Date
BRPI0615630A2 true BRPI0615630A2 (en)	2016-11-16

Family

ID=37697999

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0615630A BRPI0615630A2 (en)	2005-09-08	2006-09-06	pharmaceutical composition and use of sertindole

Country Status (17)

Country	Link
EP (1)	EP1924261A1 (en)
JP (1)	JP2009507051A (en)
KR (1)	KR20080042102A (en)
CN (1)	CN101257906A (en)
AR (1)	AR056475A1 (en)
AU (1)	AU2006322460A1 (en)
BR (1)	BRPI0615630A2 (en)
CA (1)	CA2621866A1 (en)
EA (1)	EA013167B1 (en)
IL (1)	IL189541A0 (en)
MX (1)	MX2008002290A (en)
NO (1)	NO20081721L (en)
NZ (1)	NZ565330A (en)
TW (1)	TW200738239A (en)
UA (1)	UA97349C2 (en)
WO (1)	WO2007065448A1 (en)
ZA (1)	ZA200801169B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI320783B (en)	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
EP2382971A4 (en) *	2009-01-29	2014-01-08	Dainippon Sumitomo Pharma Co	Orally disintegrating tablet having inner core
FR2943061B1 (en) *	2009-03-13	2011-02-25	Rhodia Operations	ORGANOPHOSPHORUS COMPOUNDS, CATALYTIC SYSTEMS COMPRISING THESE COMPOUNDS, AND HYDROCYANATION OR HYDROFORMYLATION PROCESS USING THESE CATALYTIC SYSTEMS
SMT201800565T1 (en)	2012-07-16	2018-11-09	Fibrogen Inc	Crystalline forms of a prolyl hydroxylase inhibitor
US8883823B2 (en)	2012-07-16	2014-11-11	Fibrogen, Inc.	Crystalline forms of a prolyl hydroxylase inhibitor
WO2014197660A1 (en)	2013-06-06	2014-12-11	Fibrogen, Inc.	Pharmaceutical formulations of a hif hydroxylase inhibitor
CN105636585B (en) *	2013-11-19	2020-02-07	西佳技术公司	Rehydration of micronized tecovirimat monohydrate
JP2018172361A (en) *	2016-10-14	2018-11-08	大原薬品工業株式会社	Solid preparation containing duloxetine, having improved light stability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04346929A (en) *	1991-05-22	1992-12-02	Takada Seiyaku Kk	Bromocriptine mesylate preparation having stability to light
EP0906104A4 (en) *	1996-03-25	2003-12-10	Lilly Co Eli	Method for treating pain
ZA973433B (en) *	1996-04-24	1997-12-10	Shionogi & Co	A sertindole-containing preparation and a method for producing the same.
ZA977967B (en) *	1996-09-23	1999-03-04	Lilly Co Eli	Combination therapy for treatment of psychoses

2006
- 2006-06-09 UA UAA200803569A patent/UA97349C2/en unknown
- 2006-08-17 TW TW095130202A patent/TW200738239A/en unknown
- 2006-08-29 AR ARP060103764A patent/AR056475A1/en not_active Application Discontinuation
- 2006-09-06 KR KR1020087004910A patent/KR20080042102A/en not_active Withdrawn
- 2006-09-06 ZA ZA200801169A patent/ZA200801169B/en unknown
- 2006-09-06 WO PCT/DK2006/050038 patent/WO2007065448A1/en not_active Ceased
- 2006-09-06 EP EP06846966A patent/EP1924261A1/en not_active Withdrawn
- 2006-09-06 MX MX2008002290A patent/MX2008002290A/en not_active Application Discontinuation
- 2006-09-06 AU AU2006322460A patent/AU2006322460A1/en not_active Abandoned
- 2006-09-06 CA CA002621866A patent/CA2621866A1/en not_active Abandoned
- 2006-09-06 EA EA200800774A patent/EA013167B1/en not_active IP Right Cessation
- 2006-09-06 BR BRPI0615630A patent/BRPI0615630A2/en not_active IP Right Cessation
- 2006-09-06 CN CNA2006800323410A patent/CN101257906A/en active Pending
- 2006-09-06 JP JP2008529472A patent/JP2009507051A/en not_active Withdrawn
- 2006-09-06 NZ NZ565330A patent/NZ565330A/en not_active IP Right Cessation
2008
- 2008-02-14 IL IL189541A patent/IL189541A0/en unknown
- 2008-04-08 NO NO20081721A patent/NO20081721L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2007065448A1 (en)	2007-06-14
EP1924261A1 (en)	2008-05-28
MX2008002290A (en)	2008-03-14
UA97349C2 (en)	2012-02-10
EA013167B1 (en)	2010-02-26
CA2621866A1 (en)	2007-06-14
NZ565330A (en)	2011-06-30
JP2009507051A (en)	2009-02-19
AU2006322460A1 (en)	2007-06-14
CN101257906A (en)	2008-09-03
ZA200801169B (en)	2010-07-28
TW200738239A (en)	2007-10-16
IL189541A0 (en)	2008-08-07
EA200800774A1 (en)	2008-06-30
KR20080042102A (en)	2008-05-14
NO20081721L (en)	2008-04-08
AR056475A1 (en)	2007-10-10

Publication	Publication Date	Title
BRPI0614205A2 (en)	2016-11-22	compound, pharmaceutical composition and compound use
BRPI0618904A2 (en)	2016-09-13	compound, pharmaceutical composition, and compound use
BRPI0720124A2 (en)	2014-03-04	PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
BRPI0819299A2 (en)	2014-10-07	USE OF COMPOSITION, AND, COMPOSITION CONTAINING PROTEIN
BRPI0609802A2 (en)	2017-05-02	compound, pharmaceutical composition and use of a compound
HUS1400051I1 (en)	2016-10-28	Pharmaceutical composition containing lurazidone
CR10725A (en)	2009-05-12	PIRAZOLINE COMPOUNDS AND THEIR USE AND PHARMACEUTICAL COMPOSIONS
NO20075628L (en)	2007-11-05	Pharmaceutical formulations
BRPI0912717A2 (en)	2014-12-23	PHARMACEUTICAL COMPOSITION, AND, USE OF 5-AZACYTIDINE
BRPI0821115A2 (en)	2015-06-16	Aminotriazole-derived compound, drug, pharmaceutical composition and use of compound
ITBO20050123A1 (en)	2005-06-06	GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA
IL191759A (en)	2015-05-31	Genaxolone preparations and methods for their preparation and use
BRPI0716171A2 (en)	2013-09-17	compound, pharmaceutical composition and use of a compound.
BRPI0814593A2 (en)	2015-01-20	COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
BRPI0815190A2 (en)	2015-03-31	Pyridine derivative compound, pharmaceutical composition comprising it and use thereof
BRPI0716327A2 (en)	2014-03-04	Phenylpropionamide Compound and Use
DK1940467T3 (en)	2017-02-13	Long-release drug composition
BRPI0813587A2 (en)	2014-12-30	COMPOUND, USE OF THE SAME, AND PHARMACEUTICAL COMPOSITION
BRPI0716698A2 (en)	2014-02-25	COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND
BRPI0815768A2 (en)	2014-09-30	USE OF UV ABSORBENTS, AND, COSMETIC COMPOSITION.
EP1890677A4 (en)	2013-01-30	Pharmaceutical compositions and use thereof
BRPI0911772A2 (en)	2017-06-27	compound, pharmaceutical composition, and use of the compound.
BRPI0720323A2 (en)	2016-08-09	compound, method of treatment, pharmaceutical composition and use of the compound
BRPI0910570A2 (en)	2015-09-22	use of bioconjugates and pharmaceutical formulations
DK2033629T3 (en)	2013-02-04	Solid pharmaceutical composition comprising valsartan

Legal Events

Date	Code	Title	Description
2012-03-06	B06G	Technical and formal requirements: other requirements [chapter 6.7 patent gazette]	Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.
2013-01-22	B11Z	Dismissal: petition dismissal - article 216, par 2 of industrial property law	Free format text: REFERENTE A PETICAO NO 20080033994/RJ DE 06/03/2008.
2016-11-01	B06H	Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]	Free format text: O DESPACHO 6.7 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.
2016-11-08	B11M	Decision cancelled [chapter 11.13 patent gazette]	Free format text: (O DESPACHO 11.6.1 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.
2017-02-07	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2017-05-30	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]